B Falkowska-Gilska | PubMed Health

PubMed2000

[Single use insulin injector evaluated by patients (questionnaire study)].

The aim of the study was the analysis of perception of the disposable pen injector HumaJect by diabetic patients. Selected features of the insulin delivery systems were evaluated, and on that basis, the comparison between HumaJect and other insulin injectors was made. Research material was collected in questionnaires filled out by doctors after interviewing patients who were using HumaJect for at least one month. 1802 diabetic individuals aged 9 to 88 participated in the study. HumaJect was ranked "very good" (which is the highest possible rank) by 71% of patients. Among specific features, the highest ranks were assigned to "Ease of dose setting", "Dosing range" and "Disposable form". Most of patients assigned higher ranks to HumaJect than to other insulin delivery systems. 89% of patients indicated desire to continue treatment with this injector.

Adolescent↗

PubMed1998

[The effect of an education and rehabilitation program for blind diabetics on the level of metabolic equalization].

AIM: Evaluating efficiency of the education and rehabilitation programme for patients suffering from diabetes on the level of metabolic equalization. Two modules for patients have been introduced. The first is group education conducted in groups of 20 patients. This covers basic information concerning diabetes, self-monitoring interventional actions and using the insulin-injector. The second model is repeated every three months: one-day observation in a room for daily-basis patients, which is combined with an individual educational programme and evaluation of metabolic equalization. After 6 and 24 months the level of patients knowledge was checked with the test containing 12 questions and with application of 1-5 point scale. The state of metabolic equalization was also tested, by means of evaluating the average glycaemia, serum concentration of HbA1c and the dosage of insulin. The level of patients knowledge increased after 6 months from 39 +/- 18% to 44 +/- 19%, and after 24 months by 68 +/- 21. The average glycaemia was lowered from 14.04 +/- 9.32 to 8.10 +/- 5.05 mmol/l after 24 months. The average serum cholesterol level was lowered from 6.7 +/- 1.21 to 6.51 +/- 1.39 mmol/l. At the same time there was an increase in the fractions HDL from 1.26 +/- 0.32 to 1.34 +/- 0.46 mmol/l HbA1c from 10.1 +/- 1.4% to 8.5 +/- 1.2%. The daily dose of insulin was reduced from 58.6 +/- 29.3 units a day 44.2 +/- 22.1 +/- units a day. A positive body weight reduction was observed. BMI was lowered from 30.1 +/- 3.96 to 28 +/- 5 kg/m2.

Adult↗